Nucleome Looks To Decode The ‘Dark Genome’ With New Technology
Insights From CEO Danuta Jeziorska
Executive Summary
Despite accounting for 98% of our DNA, the ‘dark genome’ has yet to be effectively harnessed for drug discovery. Nucleome Therapeutics’ new modeling technology could finally provide the tools that have been missing, says CEO Danuta Jeziorska.